The expression and activity of IDO1 are increased in many cancers, and this is considered a negative prognostic indicator for esophageal [35] and colorectal [36] cancers, thyroid carcinoma [37], non-small cell lung cancer [38], and OSCC [23,39]. This evidence concerns the gene IDO1 and thyroid gland carcinoma.